Suivre
Frederic Pouliot
Frederic Pouliot
CHU de Québec
Adresse e-mail validée de crchudequebec.ulaval.ca
Titre
Citée par
Citée par
Année
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
RJ Motzer, B Escudier, S Oudard, TE Hutson, C Porta, S Bracarda, ...
The Lancet 372 (9637), 449-456, 2008
36912008
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
BI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...
New England Journal of Medicine 380 (12), 1116-1127, 2019
27602019
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open …
T Powles, ER Plimack, D Soulières, T Waddell, V Stus, R Gafanov, ...
The Lancet Oncology 21 (12), 1563-1573, 2020
5882020
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
528*2021
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery
K Bensalah, AJ Pantuck, N Rioux-Leclercq, R Thuret, F Montorsi, ...
European urology 57 (3), 466-473, 2010
3312010
Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFβ signaling
C Ringuette Goulet, G Bernard, S Tremblay, S Chabaud, S Bolduc, ...
Molecular Cancer Research 16 (7), 1196-1204, 2018
2572018
Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
CR Goulet, A Champagne, G Bernard, D Vandal, S Chabaud, F Pouliot, ...
BMC cancer 19, 1-13, 2019
2312019
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer …
KJ Pienta, MA Gorin, SP Rowe, PR Carroll, F Pouliot, S Probst, ...
The Journal of urology 206 (1), 52-61, 2021
2212021
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
MJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ...
Clinical Cancer Research 27 (13), 3674-3682, 2021
2172021
Contemporary management of renal tumors with venous tumor thrombus
F Pouliot, B Shuch, JC LaRochelle, A Pantuck, AS Belldegrun
The Journal of urology 184 (3), 833-841, 2010
2032010
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy
J Escamilla, S Schokrpur, C Liu, SJ Priceman, D Moughon, Z Jiang, ...
Cancer research 75 (6), 950-962, 2015
1882015
Open-label, single-arm, phase II study of pembrolizumab monotherapy as first-line therapy in patients with advanced non–clear cell renal cell carcinoma
DF McDermott, JL Lee, M Ziobro, C Suarez, P Langiewicz, VB Matveev, ...
Journal of Clinical Oncology 39 (9), 1029, 2021
1502021
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
T Azad, HJ Janse van Rensburg, ED Lightbody, B Neveu, A Champagne, ...
Nature communications 9 (1), 1061, 2018
1372018
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor …
BI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...
Journal of Clinical Oncology 37 (15_suppl), 4500-4500, 2019
1222019
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma (ccRCC): Results from 42-month follow-up of …
BI Rini, ER Plimack, V Stus, T Waddell, R Gafanov, F Pouliot, D Nosov, ...
Journal of Clinical Oncology 39 (15_suppl), 4500-4500, 2021
1212021
Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma: results from cohort A of KEYNOTE-427
DF McDermott, JL Lee, C Szczylik, F Donskov, J Malik, BY Alekseev
J Clin Oncol 36 (Suppl. 15_suppl), 4500, 2018
1212018
Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells
F Pouliot, A Blais, C Labrie
Cancer research 63 (2), 277-281, 2003
1182003
Role of Smad1 and Smad4 proteins in the induction of p21 WAF1, Clp1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells
F Pouliot, C Labrie
Journal of endocrinology 172 (1), 187-198, 2002
1112002
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
C COVIDSurg, C GlobalSurg
Anaesthesia 77 (1), 28-39, 2022
972022
Is routine renal tumor biopsy associated with lower rates of benign histology following nephrectomy for small renal masses?
PO Richard, LT Lavallée, F Pouliot, M Komisarenko, L Martin, JB Lattouf, ...
The Journal of urology 200 (4), 731-736, 2018
902018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20